SOLUTIONS

Solution

Reflect deeply, pool wisdom, and pursue excellence.

Release time:

2020-09-10 13:30

Source:

Hematologic Malignancies Two-thirds of our project managers and directors have experience in hematologic oncology. Our research network covers the entire country; a single pivotal clinical study alone manages 80 hematology clinical sites, with collaboration involving key opinion leaders and department directors. Over the past five years, our team has conducted more than 20 clinical trials for hematologic malignancies, enrolling over 3,000 patients across the following indications: Leukemia Lymphoma Multiple myeloma Chronic Myelomonocytic Leukemia Non-Hodgkin Lymphoma Myeloproliferative Neoplasms Cell Therapy (Stem Cells and Immune Cells) Over the past five years, our team has conducted more than 10 cell therapy studies and successfully helped clients overcome numerous technical challenges, enabling them to obtain clinical approvals. We possess specialized expertise, technical skills, and extensive experience. We have a deep understanding of the regulatory policies specific to this field. We have extensive experience in registering clinical trials and conducting Investigational New Drug (IIT) studies. Immune cells are primarily used in cancer treatment, while stem cells are more focused on tissue repair and the treatment of chronic diseases. Currently, cell therapy has already seen widespread application in hematologic disorders and demonstrates favorable outcomes—for example, CAR-T cell therapy has achieved an 82% response rate in patients with acute lymphoblastic leukemia. Cell therapy is also playing an increasingly important role in the exploration and treatment of solid tumors.
Reflect deeply, pool wisdom, and pursue excellence.
Reflect deeply, pool wisdom, and pursue excellence.

Hematologic malignancies

 

We 2/3 The project managers and directors have experience in hematologic oncology.

The study network covers the entire country, managing only one pivotal clinical trial. 80 The home blood clinical base collaborates with key opinion leaders and directors.

Over the past five years, the team has carried out more than 20 A clinical trial on hematologic malignancies, which studied... 3000 Multiple patients, including those with the following indications:

Leukemia

Lymphoma

Multiple myeloma

Chronic Myelomonocytic Leukemia

Non-Hodgkin lymphoma

Myeloproliferative neoplasms

 

 

Cell therapy (stem cells and immune cells)

 

Over the past five years, our team has carried out more than 10 The remaining cell therapy studies have been successfully completed, and we have helped clients overcome numerous technical challenges to obtain clinical approvals.

Possesses specialized knowledge, technical skills, and practical experience.

Understand the regulatory policies specific to the context of this field.

Registered clinical trials and IIT Rich research experience.

Immune cells are primarily used in cancer treatment, while stem cells are more geared toward tissue repair and the treatment of chronic diseases.

Currently, cell therapy has already seen extensive application in hematological diseases and offers favorable prognoses (e.g., ...). CAR-T Cell therapy has led to improvement in the condition of patients with acute lymphoblastic leukemia. 82% ), cell therapy is also playing a role in the exploration and treatment of solid tumors.

Recommended Services

Registration Affairs

Registration Affairs

View details

Early clinical development

Early clinical development

View details

Phase II-IV Clinical Trials

Phase II-IV Clinical Trials

View details

Post-Marketing Reevaluation Study

Post-Marketing Reevaluation Study

View details

Medical Affairs

Medical Affairs

View details

Quality Assurance Services

Quality Assurance Services

View details

Generic Drug Clinical Studies

Generic Drug Clinical Studies

View details

Personnel Outsourcing (FSP) Services

Personnel Outsourcing (FSP) Services

View details

Recommended News